Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution

Go back to Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
(NASDAQ: ETON) Delayed: 49.68 -0.51 (1.02%)
Previous Close $50.19    52 Week High $ 
Open $50.93    52 Week Low $ 
Day High $50.93    P/E N/A 
Day Low $48.66    EPS $ 
Volume 175,855